(CUE) Cue Biopharma complete technical analysis [charts+indicators] | Buy/Sell Cue Biopharma | (CUE) share price targets
Complete technical analysis of Cue Biopharma (CUE) by charts plus indicators, forecast predictions and share price targets for Cue Biopharma (CUE)
Cue Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-05 View latest technical analysis
10 day averaged volume of Cue Biopharma is 634340
Date | Daily Closing Price | Open | High | Low | Volume |
05 Tue Nov 2024 | 1.71 | 1.48 | 1.74 | 1.32 | 1.291 times |
04 Mon Nov 2024 | 1.49 | 1.51 | 1.64 | 1.45 | 0.678 times |
01 Fri Nov 2024 | 1.52 | 1.65 | 1.69 | 1.43 | 0.914 times |
31 Thu Oct 2024 | 1.61 | 1.72 | 1.74 | 1.48 | 1.057 times |
30 Wed Oct 2024 | 1.75 | 1.71 | 1.90 | 1.69 | 0.934 times |
29 Tue Oct 2024 | 1.69 | 1.75 | 1.95 | 1.60 | 1.233 times |
28 Mon Oct 2024 | 1.78 | 1.46 | 1.86 | 1.46 | 1.358 times |
25 Fri Oct 2024 | 1.48 | 1.54 | 1.63 | 1.31 | 1.396 times |
24 Thu Oct 2024 | 1.56 | 1.63 | 1.68 | 1.50 | 0.75 times |
23 Wed Oct 2024 | 1.57 | 1.60 | 1.61 | 1.50 | 0.583 times |
My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 1.7, but if it comes below 1.7, then a intra day sell could be more profitable.
If you take a sell trade below 1.7, then use 1.7 as stoploss and 1.45 as target. However if you take a buy trade in stock , then use 1.7 as stoploss and 2 as target.
Share price targets for Cue Biopharma (CUE)
Target Type | Value |
Downside Target | 0.45 |
Downside Target | 0.58 |
Downside Target | 0.62 |
Downside Target | 0.68 |
Downside Target | 0.71 |
Downside Target | 0.77 |
Downside Target | 0.99 |
Downside Target | 1.28 |
Downside Target | 1.32 |
Downside Target | 1.43 |
Downside Target | 1.46 |
Upside Target | 1.74 |
Upside Target | 1.90 |
Upside Target | 1.95 |
Intraday share price targets for Cue Biopharma (CUE)
Target Type | Value |
Downside Intraday Target | 1.44 |
Downside Intraday Target | 1.17 |
Upside Intraday Target | 1.86 |
Upside Intraday Target | 2.01 |
Downside Intraday Target | 1.59 |
Weekly technical analysis of Cue Biopharma (CUE)
Date | Weekly Closing Price | Open | High | Low | Volume |
05 Tue Nov 2024 | 1.71 | 1.51 | 1.74 | 1.32 | 0.358 times |
01 Fri Nov 2024 | 1.52 | 1.46 | 1.95 | 1.43 | 0.438 times |
25 Fri Oct 2024 | 1.48 | 1.33 | 1.90 | 1.28 | 4.374 times |
18 Fri Oct 2024 | 1.21 | 1.20 | 1.28 | 0.99 | 0.281 times |
11 Fri Oct 2024 | 1.23 | 1.19 | 1.46 | 0.71 | 0.752 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Cue Biopharma (CUE)
Date | Monthly Closing Price | Open | High | Low | Volume |
05 Tue Nov 2024 | 1.71 | 1.65 | 1.74 | 1.32 | 0.07 times |
31 Thu Oct 2024 | 1.61 | 0.77 | 1.95 | 0.68 | 2.852 times |
30 Mon Sep 2024 | 0.76 | 0.72 | 0.77 | 0.45 | 1.921 times |
30 Fri Aug 2024 | 0.72 | 0.83 | 1.00 | 0.58 | 0.315 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Cue Biopharma (CUE)
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Cue Biopharma ( (CUE) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Cue Biopharma ( (CUE) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Cue Biopharma stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Cue Biopharma in short term but the sell signal is initial and weak.
Cue Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Cue Biopharma in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Cue Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.63 and Cue Biopharma (CUE) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Cue Biopharma (CUE) stock. Volume based technical analysis of Cue Biopharma (CUE) stock is negative.
Cue Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Cue Biopharma ( (CUE) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Cue Biopharma ( (CUE) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Cue Biopharma stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Cue Biopharma in short term but the sell signal is initial and weak.
Cue Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Cue Biopharma in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Cue Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.63 and Cue Biopharma (CUE) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Cue Biopharma (CUE) stock. Volume based technical analysis of Cue Biopharma (CUE) stock is negative.
Cue Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.